October 2016

Global Acne Therapeutics Market – Growth, Trends and Forecasts (2016 – 2021)

Purchase Report
Single user license
Team license
Corporate license

The global acne therapeutics market is expected to grow at a CAGR of XX% during the forecast period 2016-2021. The market was estimated to be USD XX million in 2015 and is forecasted to reach USD XX million by 2021.

Acne is one of the most common skin disorders in the United States, currently, affecting almost 40 – 50 million Americans, annually. The American Academy of Dermatology states that approximately 85% of people between the ages of 12 and 24 years’ experience at least minor acne. The costs associated with the treatment of acne currently exceed USD 3 billion.  The acne market awaits a blockbuster drug; most of the current pipeline products consist of combination products with very few first-in-class molecules. Emerging products are also not significantly different from the current monotherapies.

Global Acne Therapeutics - Market Dynamics

The report details several factors driving and restraining the market, some of which are discussed below.


  • Increasing sedentary lifestyle and unhealthy food habits
  • Rise in disposable income of consumers
  • Increasing awareness about current and upcoming acne treatments
  • High global acne prevalence


  • The safety issues regarding the products
  • Entry of Generics in the acne treatment drug market

Market Segmentation

The global acne therapeutics market has been segmented by treatment into therapeutics and other treatments. The therapeutics segment is further segmented into antibiotics (erythromycin and clindamycin), retinoid (adapalene, tazaroteen, tretinoin and isotretinoin), combination medications, anti-inflammatory, hormonal agents and other agents (azelaic acid and resorcinol). Other treatments include laser and light therapy, cosmetic procedures and acne scar treatment. The market has been geographically segmented into North America, Europe, Asia-Pacific, and Rest of the World.

Some of the key players in the market are:

  • Allergan 
  • Galderma 
  • Stiefel Laboratories, Inc.
  • Valeant Pharmaceutical International Inc.
  • Johnson & Johnson Private Limited
  • Cipher
  • GlaxoSmithKline
  • Teva
  • Ranbaxy
  • Bayer AG
  • Others

What the Report Offers

  • Market definition, along with identification of key drivers and restraints for the market.
  • Market analysis with region-specific assessments and competition analysis on a global and regional scale.
  • Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
  • Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
  • Identification and analysis of the macro and micro factors that affect the industry on both global and regional scale.
  • A comprehensive list of key market players, along with the analysis of their current strategic interests and key financial information.
  • An ideal source material for industry consultants, manufacturers and other interested and allied parties to gain critical insight into the factors driving and restraining the market, in addition to opportunities, offered.
No related reports available.
Purchase Report
Single user license
Team license
Corporate license
Our Clients Include View All

Looking to Customize Report?